» Articles » PMID: 27672290

Role of MiRNAs and Their Potential to Be Useful As Diagnostic and Prognostic Biomarkers in Gastric Cancer

Abstract

Alterations in epigenetic control of gene expression play an important role in many diseases, including gastric cancer. Many studies have identified a large number of upregulated oncogenic miRNAs and downregulated tumour-suppressor miRNAs in this type of cancer. In this review, we provide an overview of the role of miRNAs, pointing to their potential to be useful as diagnostic and/or prognostic biomarkers in gastric cancer. Moreover, we discuss the influence of polymorphisms and epigenetic modifications on miRNA activity.

Citing Articles

Treasures from trash in cancer research.

Moreira F, Sarquis D, de Souza J, Avelar D, Araujo T, Khayat A Oncotarget. 2022; 13:1246-1257.

PMID: 36395362 PMC: 9671455. DOI: 10.18632/oncotarget.28308.


Circular RNA circ_SKA3 enhances gastric cancer development by targeting miR-520h.

Wang C, Jiang H, Peng J, Weng D, Zhang Y, Zhou Y Histol Histopathol. 2022; 38(3):317-328.

PMID: 36134741 DOI: 10.14670/HH-18-521.


Retracted Article: Long non-coding RNA XIST promotes proliferation, autophagy and inhibits apoptosis by regulating microRNA-30c/ATG5 axis in gastric cancer.

Liu M, Zhao H, Sheng M, Li H RSC Adv. 2022; 8(65):37508-37517.

PMID: 35557796 PMC: 9089405. DOI: 10.1039/c8ra07852a.


Expression differences of miR-142-5p between treatment-naïve chronic myeloid leukemia patients responding and non-responding to imatinib therapy suggest a link to oncogenic ABL2, SRI, cKIT and MCL1 signaling pathways critical for development of....

Klumper T, Bruckmueller H, Diewock T, Kaehler M, Haenisch S, Pott C Exp Hematol Oncol. 2020; 9:26.

PMID: 32999756 PMC: 7519530. DOI: 10.1186/s40164-020-00183-1.


Regulation of Long Non-coding RNAs and MicroRNAs in Heart Disease: Insight Into Mechanisms and Therapeutic Approaches.

Collins L, Binder P, Chen H, Wang X Front Physiol. 2020; 11:798.

PMID: 32754048 PMC: 7365882. DOI: 10.3389/fphys.2020.00798.


References
1.
Feng L, Xie Y, Zhang H, Wu Y . miR-107 targets cyclin-dependent kinase 6 expression, induces cell cycle G1 arrest and inhibits invasion in gastric cancer cells. Med Oncol. 2011; 29(2):856-63. DOI: 10.1007/s12032-011-9823-1. View

2.
Zhou Y, Du W, Chen G, Ruan J, Xu S, Zhou F . Association analysis of genetic variants in microRNA networks and gastric cancer risk in a Chinese Han population. J Cancer Res Clin Oncol. 2012; 138(6):939-45. DOI: 10.1007/s00432-012-1164-8. View

3.
Vickers K, Palmisano B, Shoucri B, Shamburek R, Remaley A . MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol. 2011; 13(4):423-33. PMC: 3074610. DOI: 10.1038/ncb2210. View

4.
Yang J, Lai E . Alternative miRNA biogenesis pathways and the interpretation of core miRNA pathway mutants. Mol Cell. 2011; 43(6):892-903. PMC: 3176435. DOI: 10.1016/j.molcel.2011.07.024. View

5.
Tong A, Nemunaitis J . Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy?. Cancer Gene Ther. 2008; 15(6):341-55. DOI: 10.1038/cgt.2008.8. View